INVESTIGATION OF INSULIN RESISTANCE IN NEW-ONSET DIABETES AFTER KIDNEY TRANSPLANTATION

Dung Nguyễn Thị Thùy, Thắng Lê Việt, Núi Nguyễn Minh

Main Article Content

Abstract

Objective: To investigate insulin levels and insulin resistance in patients with new-onset diabetes after kidney transplantation (NODAT). Subjects and Methods: A descriptive cross-sectional study was conducted on 81 patients with NODAT, 81 post-kidney transplant patients without diabetes, and 53 age- and sex-matched healthy controls at the 103 Military Hospital from October 2021 to December 2023. Clinical and laboratory data were collected, and insulin resistance indices were calculated using the HOMA2 model, including insulin resistance (HOMA2-IR), insulin sensitivity (HOMA2-S), and beta-cell function (HOMA2-B). Results: The HOMA2-IR index was highest in the NODAT group (0.95), higher than in the non-NODAT group (0.82), and lowest in the healthy control group (0.7), p < 0.001, respectively. Conversely, insulin sensitivity (HOMA2-S) and beta-cell function (HOMA2-B) were lowest in the NODAT group, followed by the non-NODAT group, and highest in the healthy control group, p < 0.001. Among NODAT patients, those with hypertension had higher insulin resistance and lower insulin sensitivity compared to those without hypertension, p < 0.05. Abdominal obesity and BMI showed a positive correlation with HOMA2-IR and insulin levels and a negative correlation with HOMA2-S, p < 0.05. The trough level of Tacrolimus was negatively correlated with HOMA2-IR and insulin levels while positively correlated with HOMA2-S (p < 0.05). Conclusion: Insulin resistance is common and is associated with increased waist circumference, BMI, and trough levels of Tacrolimus in patients with NODAT. 

Article Details

References

1. Liyanage T., Ninomiya T., Jha V., et al. (2015). Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet, 385(9981): 1975-82.
2. Palepu S. and Prasad G. V. (2015). New-onset diabetes mellitus after kidney transplantation: Current status and future directions. World J Diabetes, 6(3): 445-55.
3. Pham P. T., Pham P. M., Pham S. V., et al. (2011). New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes, 4: 175-86.
4. Ahmed S. H., Biddle K., Augustine T., et al. (2020). Post-Transplantation Diabetes Mellitus. Diabetes Ther, 11(4): 779-801.
5. Cai R., Wu M., Lin M., et al. (2019). Pretransplant Homeostasis Model Assessment of Insulin Resistance and Fasting Plasma Glucose Predict New-Onset Diabetes After Renal Transplant in Chinese Patients. Transplant Proc, 51(3): 768-773.
6. Sharif A., Hecking M., de Vries A. P., et al. (2014). Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant, 14(9): 1992-2000.
7. Hội tim mạch quốc gia Việt Nam (2018). Khuyến cáo chẩn đoán và điều trị tăng huyết áp, trang 1-7.
8. Bộ Y tế (2015). Rối loạn chuyển hóa lipid máu. Hướng dẫn chẩn đoán và điều trị một số bệnh nội tiết- chuyển hóa. Nhà xuất bản Y học, trang 255-258.
9. Seo M.H. L. W. Y., Kim S.S., et al (2019). Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea. J Obes Metab Syndr, 28(1):40-45.
10. Bang J. B., Oh C. K., Kim Y. S., et al. (2020). Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study. Endocrinol Metab (Seoul), 35(4): 820-829.